TRAVOPROST 0.004%w/v IP + BENZALKONIUM CHLORIDE SOLUTION 0.02%v/v IP

A prostaglandin analogue ophthalmic solution that reduces intraocular pressure in patients affected with glaucoma and ocular hypertension. (Luciano Quaranta, 2015) Provides intraocular pressure control superior to timolol 0.5% in patients with open-angle glaucoma or ocular hypertension. (Mark R Hellberg, 2002) Lowers the intraocular pressure by facilitating the aqueous humor outflow. (Weeranuj Yamreudeewong, 2010) An effective intraocular pressure-lowering medication, providing 6.5–9.0 mmHg of intraocular pressure reduction. (Philippe Denis, 2007) Offers significantly greater decrease in intraocular pressure compared with latanoprost 0.005% in patients with open-angle glaucoma or ocular hypertension. (Eugenio Maul, 2007) A first-line treatment for patients affected with elevated intraocular pressure. (Luciano Quaranta, 2015) A safe and well-tolerated agent in patients with open-angle glaucoma or ocular hypertension. (Ronald L Fellman, 2002) An effective topical agent for the treatment of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension. (Adel M Al-Jazzaf, 2003)